quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:09·1620d
SECFiling
Kadmon Holdings, Inc. logo

SEC Form EFFECT filed by Kadmon Holdings, Inc.

KDMN· Kadmon Holdings, Inc.
Health Care
Original source

Companies

  • KDMN
    Kadmon Holdings, Inc.
    Health Care

Recent analyst ratings

  • Sep 14UpdateMizuho$9.50
  • Sep 9UpdateJefferies$9.50
  • Jul 19UpdateOppenheimer$9.00

Related

  • PR423d
    Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
  • PR1088d
    Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors
  • SEC1616d
    SEC Form 15-12B filed by Kadmon Holdings, Inc.
  • SEC1620d
    SEC Form EFFECT filed by Kadmon Holdings, Inc.
  • INSIDER1626d
    SEC Form 4: Flowers Cynthia Louise gifted 20,150 shares and returned $103,075 worth of shares to the company (10,850 units at $9.50), closing all direct ownership in the company
  • INSIDER1626d
    SEC Form 4 filed by Cohen David E
  • INSIDER1626d
    SEC Form 4 filed by Ryan John L
  • INSIDER1626d
    SEC Form 4: Waksal Harlan returned $1,690,478 worth of shares to the company (177,945 units at $9.50), closing all direct ownership in the company
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022